We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Clorox
CLX
$11.1B
| $11.8M | 0.01% |
123,754
-223,655
| -64% | -$21.5M |
|
952
PACS Group
PACS
$6.91B
| $11.8M | 0.01% |
276,795
+211,707
| +325% | +$7.61M |
|
953
Arcutis Biotherapeutics
ARQT
$3.07B
| $11.7M | 0.01% |
446,866
-1,984,912
| -82% | -$46.2M |
|
954
TJX Companies
TJX
$142B
| $11.7M | 0.01% |
77,250
-280,006
| -78% | -$44.3M |
|
955
O-I Glass
OI
$1.04B
| $11.7M | 0.01% |
1,213,646
+825,264
| +212% | +$7.76M |
|
956
CALL
Seagate
STX
$205B
| $11.6M | 0.01% |
12,000
+9,100
| +314% | +$6.94M |
|
957
Markel Group
MKL
$22.1B
| $11.6M | 0.01% |
5,929
-47,971
| -89% | -$89.6M |
|
|
JHG
958
DELISTED
Janus Henderson
JHG
| $11.6M | 0.01% |
222,776
-9,200
| -4% | -$476K |
|
959
CALL
Alibaba
BABA
$280B
| $11.5M | 0.01% |
120,200
+64,500
| +116% | +$8.08M |
|
960
CALL
Coinbase
COIN
$47.2B
| $11.5M | 0.01% |
78,800
+12,800
| +19% | +$2.31M |
|
961
Freshworks
FRSH
$3.16B
| $11.5M | 0.01% |
1,137,794
+60,812
| +6% | +$542K |
|
962
LiveRamp
RAMP
$2.29B
| $11.5M | 0.01% |
305,311
+234,639
| +332% | +$7.73M |
|
963
Lithia Motors
LAD
$8.11B
| $11.5M | 0.01% |
39,540
-159,823
| -80% | -$45.4M |
|
964
iShares MSCI Emerging Markets ETF
EEM
$32B
| $11.4M | 0.01% |
167,260
+99,860
| +148% | +$6.52M |
|
965
Samsara
IOT
$23.4B
| $11.4M | 0.01% |
352,760
+229,408
| +186% | +$7.1M |
|
966
ArcBest
ARCB
$3.09B
| $11.4M | 0.01% |
+79,565
| New | +$10.4M |
|
967
iShares Asia 50 ETF
AIA
$5.06B
| $11.4M | 0.01% |
80,496
-8,579
| -10% | -$1.13M |
|
968
CytomX Therapeutics
CTMX
$795M
| $11.3M | 0.01% |
3,024,351
-1,113,825
| -27% | -$4.25M |
|
969
Centuri Holdings
CTRI
$2.09B
| $11.3M | 0.01% |
+373,833
| New | +$12.1M |
|
970
SI-BONE Inc
SIBN
$835M
| $11.3M | 0.01% |
690,288
+522,160
| +311% | +$7.46M |
|
971
monday.com
MNDY
$3.54B
| $11.2M | 0.01% |
155,295
+149,036
| +2,381% | +$10.9M |
|
972
Alamos Gold
AGI
$15.3B
| $11.2M | 0.01% |
370,456
+331,810
| +859% | +$13.4M |
|
973
Guidewire Software
GWRE
$12.5B
| $11.2M | 0.01% |
91,175
+81,799
| +872% | +$10.9M |
|
974
Organon & Co
OGN
$3.61B
| $11.2M | 0.01% |
828,133
-105,043
| -11% | -$1.26M |
|
975
Oxford Industries
OXM
$473M
| $11.2M | 0.01% |
321,386
+315,386
| +5,256% | +$13.1M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.